Proactive Investors - Run By Investors For Investors
Market: AIM
52-week High/Low:
Sector: Pharma & Biotech
Market Cap: 78.65M
Beximco Pharmaceuticals

Beximco Pharmaceuticals

Beximco Pharmaceuticals manufactures and sells generic pharmaceutical formulation products, active pharmaceutical ingredients, and large volume intravenous fluids to local and international markets.

Deal BXP Tax Free* Losses can exceed
your initial deposit
*subject to change and depends on individual circumstances.

Beximco Pharmaceuticals

Interactive graph

col 3
col 4
col 5
col 6

© Proactive Investors 2015

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.